Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses.
about
Microneedles: A New Frontier in Nanomedicine DeliveryPros and Cons of Antigen-Presenting Cell Targeted Tumor VaccinesDynamic visualization of dendritic cell-antigen interactions in the skin following transcutaneous immunizationDendritic cell-based vaccine efficacy: aiming for hot spotsNanoparticles from renewable polymersCutaneous immunization: an evolving paradigm in influenza vaccinesNanostructured lipid carrier-loaded hyaluronic acid microneedles for controlled dermal delivery of a lipophilic molecule.A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei.Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes.Intradermal Delivery of Antigens Enhances Specific IgG and Diminishes IgE Production: Potential Use for Vaccination and Allergy Immunotherapy.Multifunctional particle-constituted microneedle arrays as cutaneous or mucosal vaccine adjuvant-delivery systemsIn Vivo Expansion of Melanoma-Specific T Cells Using Microneedle Arrays Coated with Immune-Polyelectrolyte Multilayers.Skin-resident antigen-presenting cells: instruction manual for vaccine development.Engineering synthetic vaccines using cues from natural immunity.The role of microneedles for drug and vaccine delivery.Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology.Solid-in-oil nanodispersions for transdermal drug delivery systems.Dissolving Microneedle Patches for Dermal VaccinationTransdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis.Microneedle-mediated delivery of viral vectored vaccines.Mesoporous Silica Nanoparticle-Coated Microneedle Arrays for Intradermal Antigen DeliveryEnhanced immunization via dissolving microneedle array-based delivery system incorporating subunit vaccine and saponin adjuvant.Patient safety and beyond: what should we expect from microneedle arrays in the transdermal delivery arena?Long-lived tissue resident HIV-1 specific memory CD8+ T cells are generated by skin immunization with live virus vectored microneedle arrays.In vivo studies investigating biodistribution of nanoparticle-encapsulated rhodamine B delivered via dissolving microneedles.Human studies with microneedles for evaluation of their efficacy and safety.Polymeric microneedles for transdermal protein delivery.Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles.Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines.Flexible Macromolecule versus Rigid Particle Retention in the Injected Skin and Accumulation in Draining Lymph Nodes Are Differentially Influenced by Hydrodynamic Size.Design and characterisation of a dissolving microneedle patch for intradermal vaccination with heat-inactivated bacteria: A proof of concept studyRecent Trends in Preparation of Poly(lactide-co-glycolide) Nanoparticles by Mixing Polymeric Organic Solution with Antisolvent
P2860
Q26767037-44E4A9C0-E329-4473-94E0-7C31D6EC9BACQ27013679-D311696B-9580-45DB-9A2A-50C085BE42DCQ27320722-84D7D313-1A80-437F-ABDD-EC4D5DB9D467Q28082680-FA18349D-F369-42B5-B6F7-F5DB0BF31461Q28655569-C2D3C59F-D01B-4275-977A-B1F3374BD7D4Q30358895-C164E284-EFC8-480D-BEE0-9216D264A171Q35084780-56B6751A-7AF4-4223-81B8-E06638582D2DQ35088366-806AC172-397F-487C-96BF-D6E5851A56B6Q35132732-77DFD39F-7EC3-490A-AB15-ACED54FC9402Q35138155-745E8B8F-A753-463A-B41F-D3157B05D32CQ36223598-78C427FE-9DE1-4718-A6FD-2272612A05ACQ37197084-9742EC56-A5F8-4FE7-9BF9-DB2EE2B51AC8Q37682217-7F0D6764-D387-4ED3-AB40-B306DDEA4D1DQ38117141-0C2E8F54-92EE-4AFF-878A-4F774B4779F2Q38154804-34D5E7D2-7089-4DBE-8FC0-AE9D82F8EC64Q38229145-3C32F354-9963-4925-95C3-D699CC8C01D8Q38285751-FA978EEC-60DD-453E-ADC0-F4C00A627030Q38830870-01DB18D0-82B5-499A-8964-8E69DB653FCBQ39440948-B977123D-5954-4099-907D-23C2E5CA8F42Q40115092-DD338429-DCF3-40E1-B603-F2826969C4BAQ40596089-B6FBC221-2B23-4DCD-A0A1-2E2F6CBF1D0BQ40956743-3AFE144D-4EA3-4047-8A10-9BF00E32E1C7Q40970607-48FAA815-4B8A-411B-86CA-64AC87BB3A99Q45204909-D0457998-BE1A-4F4A-ABCA-3EED2557E245Q45325894-46AD2826-8357-4CC9-9064-939328EDDF59Q47111251-979ABE6D-F654-4B96-BF1C-19451CFABE9EQ47821469-BB3F78D3-43AF-457F-8239-019FDDF3751AQ50169459-0FB2F44F-021E-4601-9F50-E2A0A9562369Q50774170-108EDAE9-47D4-42E5-AC9B-9D856C16E54EQ50863077-C84F14B3-9219-4919-916C-E29C40EEF209Q55162750-437D6562-8C45-4CA7-BB4C-CCFE88DD13E3Q56981035-EFBFF2B2-FB74-4C38-BD31-35407F0B5472Q59113665-DB048857-1652-476D-9F1F-85FFFF5F7C8E
P2860
Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Skin dendritic cell targeting ...... nd antiviral immune responses.
@en
Skin dendritic cell targeting ...... nd antiviral immune responses.
@nl
type
label
Skin dendritic cell targeting ...... nd antiviral immune responses.
@en
Skin dendritic cell targeting ...... nd antiviral immune responses.
@nl
prefLabel
Skin dendritic cell targeting ...... nd antiviral immune responses.
@en
Skin dendritic cell targeting ...... nd antiviral immune responses.
@nl
P2093
P2860
P50
P356
P1433
P1476
Skin dendritic cell targeting ...... nd antiviral immune responses.
@en
P2093
Candice Poux
Christopher J Scott
Dorothea Terhorst
Leah Wallace
Marija Zaric
Oksana Lyubomska
Olivier Touzelet
Ryan F Donnelly
Sharifah Al-Zahrani
P2860
P304
P356
10.1021/NN304235J
P407
P577
2013-02-15T00:00:00Z